Atrinsic Inc. (NASDAQ:PTIX – Get Free Report)’s stock price traded up 1.2% on Wednesday . The stock traded as high as $0.41 and last traded at $0.41. 2,326 shares changed hands during trading, a decline of 93% from the average session volume of 34,219 shares. The stock had previously closed at $0.4050.
Atrinsic Trading Up 1.2%
The company has a 50 day moving average of $0.61 and a 200-day moving average of $0.73. The firm has a market capitalization of $742,100.00, a P/E ratio of -0.05 and a beta of 1.01.
About Atrinsic
Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.
See Also
- Five stocks we like better than Atrinsic
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.
